SMARCA2 and urinary bladder cancer: One study revealed that in patient-derived bladder cancer tumors, dysregulation of several SWI/SNF subunits (SMARCA2, INI1 and BAF155) again correlated with alterations in expression of genes involved in glucose metabolism [49].